Environmental epidemiology studies health effects of environmental exposures (air pollution, water contamination, hazardous substances, climate). Exposure assessment requires characterizing individual exposure through monitoring, biomarkers, or modeling. Environmental epidemiology often uses longitudinal designs and examines vulnerable populations, addressing how environment-disease associations vary geographically and by proximity to pollution sources.
Your prerequisite on environmental health determinants established the conceptual landscape: that exposures to air pollution, contaminated water, chemical hazards, and climate-related stressors can cause disease, and that these exposures are unequally distributed across populations and geographies. Environmental epidemiology's core methodological challenge is measuring those exposures well enough to draw valid causal inferences — and the measurement problem turns out to be formidable.
Exposure assessment is the bridge between "the environment" and "what a specific person experienced." Three main strategies exist, and each involves real tradeoffs. Ambient monitoring uses fixed sensors (air quality stations, water sampling points) to characterize the surrounding environment, then assigns exposure based on residential proximity. It is cheap and covers large populations, but it is a crude proxy: people spend time in cars, offices, and neighborhoods far from their home address, and individual behavior heavily moderates actual exposure. A person living near a highway who works from home differs enormously from a person living nearby who commutes by bicycle. Biomarkers — measuring the contaminant or its metabolites in blood, urine, hair, or tissue — capture actual internal dose, bypassing the behavioral complexity entirely. Blood lead level is a perfect example: it tells you how much lead got into the body, regardless of how. The limitation is cost, the invasiveness of collection, and the fact that biomarkers reflect recent exposure, not the lifetime accumulation that may be etiologically relevant. Dispersion modeling uses meteorological data, emission source characteristics, and atmospheric chemistry to estimate concentrations at fine spatial scales. GIS-based approaches allow mapping of predicted exposure surfaces, and assigning a modeled value to each participant's address offers a compromise between scalability and spatial precision.
Exposure misclassification is the central validity threat. When exposure is measured with error — as it always is — the effect estimate is biased. Non-differential misclassification (measurement error that is equally distributed across cases and controls or exposed and unexposed groups) typically biases associations toward the null, causing environmental health effects to be systematically underestimated. This is important: many published null findings in environmental epidemiology may reflect inadequate exposure assessment rather than absent effects. Differential misclassification (error that differs between cases and controls) can bias in either direction, which is harder to predict and correct.
Certain populations face disproportionate environmental exposures and are also more biologically vulnerable — children are the canonical example. Children breathe more air relative to body weight, have a less mature blood-brain barrier, and are in critical developmental windows where exposures to neurotoxicants (lead, methylmercury, organophosphate pesticides) can cause lasting harm at doses that would be inconsequential for adults. This combination of higher dose per kilogram and heightened developmental sensitivity means that environmental health standards derived from adult risk assessments are systematically inadequate for children, and environmental epidemiology research specifically designed around early-life exposures and developmental endpoints is essential for evidence-based policy.